Cancer Chemotherapy and Pharmacology

Search all Cancer Chemotherapy and Pharmacology articles

Volume 94, Issue 4

October 2024

15 articles in this issue

Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury
Triet P. M. Nguyen
Susan L. Woods
Joanne M. Bowen
Original Article Open access 13 July 2024 Pages: 493 - 505
Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients
Md. Siddiqul Islam
Ferdowsi Akter
Md. Wahid Akter
Original Article 16 July 2024 Pages: 507 - 516
The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients
Nobuhiro Nakazawa
Makoto Sohda
Hiroshi Saeki
Original Article 25 July 2024 Pages: 517 - 522
Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer
Dihong Yang
Gaoqi Xu
Luo Fang
Original Article 31 July 2024 Pages: 523 - 534
Effect of midostaurin on the pharmacokinetics of P-gp, BCRP, and CYP2D6 substrates: assessing potential drug-drug interactions in healthy participants
Romain Sechaud
Helen Gu
Hans D. Menssen
Original Article 07 August 2024 Pages: 535 - 547
Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19
Ming Chang
Yizhe Chen
Lu Gaohua
Original Article 07 August 2024 Pages: 549 - 559
Dexamethasone reduces cisplatin-induced hair cell damage by inducing cisplatin resistance through metallothionein-2
Haruki Ujiie
Naoyuki Nishiya
Takuya Oikawa
Original Article 14 August 2024 Pages: 561 - 569
Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter
Nohemí Salinas-Jazmín
María Adriana Medina-Mondragón
Marco Antonio Velasco-Velázquez
Original Article Open access 24 August 2024 Pages: 571 - 583
Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma
Sofia M. Sousa
Helena Branco
Cristina P. R. Xavier
Original Article Open access 03 September 2024 Pages: 585 - 597
Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway
Xiang Fei
Zhaohui Li
Qingcheng Yang
Original Article Open access 05 September 2024 Pages: 599 - 613
Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series
Takashi Masuda
Taro Funakoshi
Atsushi Yonezawa
Case Report 08 March 2024 Pages: 615 - 622
Acute kidney injury in a child treated with cisplatin and amphotericin B
Torjus Skajaa
Mia Faerch
Henrik Hasle
Case Report Open access 07 August 2024 Pages: 623 - 626
Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer
Sandi L. Navarro
Navin Pinto
Jeannine S. McCune
Brief Report 30 July 2024 Pages: 627 - 633
Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia
Wenqiang Qu
Jialing Lu
Suning Chen
Short Communication 02 March 2024 Pages: 635 - 639
Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer
Guangnan Zong
Jinlin Li
Xiuli Guo
Short Communication 07 March 2024 Pages: 641 - 645

Volume 94, Issue 4

Ferroptosis – a potential feature underlying neratinib-induced colonic epithelial injury

Impact of ALDH1A1 and NQO1 gene polymorphisms on the response and toxicity of chemotherapy in Bangladeshi breast cancer patients

The Gustave Roussy Immune score is a powerful biomarker for predicting therapeutic resistance to chemotherapy in gastric cancer patients

Population pharmacokinetic and exposure-toxicity analyses of nab-paclitaxel after pegylated recombinant human granulocyte colony-stimulating factor administration in patients with metastatic breast cancer

Effect of midostaurin on the pharmacokinetics of P-gp, BCRP, and CYP2D6 substrates: assessing potential drug-drug interactions in healthy participants

Advancements in physiologically based pharmacokinetic modeling for fedratinib: updating dose guidance in the presence of a dual inhibitor of CYP3A4 and CYP2C19

Dexamethasone reduces cisplatin-induced hair cell damage by inducing cisplatin resistance through metallothionein-2

Continuous exposure to doxorubicin induces stem cell-like characteristics and plasticity in MDA-MB-231 breast cancer cells identified with the SORE6 reporter

Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma

Avermectin B1 mediates antitumor activity and induces autophagy in osteosarcoma through the AMPK/ULK1 signaling pathway

Low serum concentrations of bevacizumab and nivolumab owing to excessive urinary loss in patients with proteinuria: a case series

Acute kidney injury in a child treated with cisplatin and amphotericin B

Pharmacogenomic associations of cyclophosphamide pharmacokinetic candidate genes with 4hydroxycyclophosphamide formation in children with Cancer

Successful use of Palbociclib combined with Venetoclax and Azacitidine in an adult with refractory/relapsed therapy-related acute myeloid leukemia

Pharmacokinetic and bioequivalence study of two capecitabine tablets in Chinese patients with solid tumor cancer

Journal navigation